Form 4 for ERNA Ernexa Therapeutics Inc.
Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-02 · accession 0001140361-22-044639 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-06 | 2022-12-02 | ERNA | Cherington Charles | Dir, 10% | P - Purchase | $3.28 | +261.8K | 556.5K | +89% | +$858.6K |
| D | 2022-12-06 | 2022-12-02 | ERNA | Cherington Charles | Dir, 10% | P - Purchase | $0.13 | +523.5K | 523.5K | New | +$68.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | P | A | 261,756 | $3.28 | 556,465 | D | — | — | (F1) The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 261,756 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules. |
| 2 | Derivative | Warrants (right to buy) | 2022-12-02 | P | A | 523,512 | $0.13 | 523,512 | D | $3.28 · 2023-06-02 to 2028-06-02 | 523,512 Common Stock, par value $0.005 per share | (F1) The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 261,756 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules. |